期刊文献+

人类软骨糖蛋白-39预测冠心病近期预后的研究

HCgp-39 on short-term prognosis in coronary heart disease
原文传递
导出
摘要 目的探讨人类软骨糖蛋白-39(human cartilage glycoprotein-39,HCgp-39)在冠心病(coronary heart disease,CAD)中的表达规律以及对冠心病30 d内心血管事件(major adverse cardiac event,MACE)的预测价值。方法2012年1月—2013年1月汉族患者181例,结合冠状动脉造影(coronary angiography,CAG)检查结果,分为急性心肌梗死(acute myocardial infarction,AMI)组56例,不稳定型心绞痛(unstable angina pectoris,UAP)组45例,稳定型心绞痛(stable angina pectoris,SAP)组40例,对照组40例,测定各组患者血浆HCgp-39水平,以及随访各组患者30 d内的MACE。计数资料比较采用χ2检验,计量资料多组比较应用单因素方差分析,相关性检验用Spearman秩相关分析,多因素分析采用多元Logistic回归分析。P<0.05为差异有统计学意义。结果 AMI组、UAP组、SAP组、对照组之间HCgp-39水平分别为(119.41±18.46)、(116.00±21.77)、(109.48±12.09)、(107.32±16.35)ng/ml,AMI组和UAP组差异无统计学意义(P>0.05);SAP组和对照组差异无统计学意义(P>0.05);HCgp-39在AMI组、UAP组中明显升高,与SAP组和对照组比较差异有统计学意义(P<0.05)。将随访30 d的MACE作为因变量,以YKL-40、糖尿病、Gensini积分、性别、年龄、高血压病、高脂血症、吸烟、冠心病家族史作为自变量,用Logistic回归分析,发现YKL-40、糖尿病与30 d内MACE关系最密切(OR值分别为1.078、3.379)。结论血浆HCgp-39水平可能反映冠状动脉粥样硬化斑块的病变性质,在冠心病30 d内MACE的发生中有一定的预测作用。 Objective To observe the rules of expression of human cartilage glycoprotein - 39 ( HCgp - 39) in coronary ar- tery disease (CAD) and its significance in predicting major adverse cardiac event(MACE) in CAD within 30 days. Methods From January 2012 to January 2013, a total of 181 patients of Han nationality were divided into four groups based on their coronary anglographic findings: acute myocardial infarction (AMI) group ( n = 56 ), unstable angina Pectoris (UAP) group ( n = 45 ) , stable angina Pectoris (SAP)group (n = 40) and control group (n = 40). All groups were detected for the plasma level of HCgp -39 and followed up for MACE within 30 days.x2 test was used for count data, single factor analysis of vari- ance for measurement data of multiple groups, Spearman rank correlation analysis for correlation; multivariate logistic re- gression analysis for multiple factors. Results ( 1 ) In terms of HCgp - 39 levels, no significant difference was found be- tween AMI group [ ( 119.41 ~ 18.46) ng/ml ] and UAP group [ ( 116.00 + 21.77 ) ng/ml ] ( P 〉 0.05 ), as well as between SAP group [ ( 109.48 ~ 12.09) ng/ml ] andcontrol group [ ( 107.32 ~ 16.35 ) ng/ml ] ( P 〉 0.05 ). Serum levels of HC gp- 39 significantly increased in AMI group and UAP group, which were significantly different from those in SAP group andcon- trol group (P 〈0.05). (2)Taking MACE within 30days as the dependent variable, YKL -40, diabetes mellltus, Genslnl score, sex, age, hypertension, hyperlipldemla, smoking, family history of CAD as the independent variable,logistlc re- gression analysis was conducted, which revealed that YKL -40 and diabetes mellitus were the most important risk factors of MACE within 30 days( OR = 1. 078,3. 379). Conclusions HCgp - 39 levels may reflect the status of coronary artery arth- eresclerosis and have a predictive role to the occurrence of MACE within 30 days.
出处 《社区医学杂志》 2013年第22期14-17,共4页 Journal Of Community Medicine
关键词 冠心病 动脉粥样硬化 人类软骨糖蛋白-39 冠状动脑造影 Coronary heart disease Artherosclersis HCgp - 39
  • 相关文献

参考文献10

  • 1Boot RG, van Achterberg TA,van Aken BE, ct al. Strong induction of members of the chitinase family of proteins in atherosclero~is: chitotri- osidase and human cartilage gp -39 expressed in lesion macrophages [J]. Arterioscler Thromb Vase Biol, 1999,19 ( 3 ) : 687 - 694.
  • 2Johansen JS, Baslund B, Garbarsch C, et al. YKL - 40 in giant cells and macrophages from patients with giant cell artefitis [ J]. Arthritis Rheum, 1999,42:2624 - 2630.
  • 3Nishikawa KC, Millis AJ. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells [ J ]. Exp Cell Res, 2003,287 : 79 87.
  • 4Wang Y, Ripa RS, Johansen JS, et al. YKL -40 a new biomarker in patients with acute coronary syndrome or stable coronary artery dis- ease[J]. Scand Cardiovasc J,2008,42(5) :295 -302.
  • 5武晓静,黄岚,周骐,赵刚,周音频,崔斌.内皮细胞生长状态与血管平滑肌细胞增殖迁移能力的关系[J].心脏杂志,2004,16(5):403-406. 被引量:3
  • 6Malinda KM, Ponce L, K, leinman HK, et al. Gp38k, a protein synthe- sized by vascular smooth muscle cells, stimulates directional migra- tion of human umbilical vein endothelial cells [ J ], Exp Cell Re.s, 1999,250 : 168 - 173.
  • 7Fach EM,Garulaean LA,Gao J,et al. In vitro biemarker discovery for atheroselerosis by proteomics[ J]. Mol Cell Proteomies ,2004,3 : 1200 -1210.
  • 8Pfeiffer A, Bottcher A, Orso E, et al. Lipopolysaecharide and eeremide Docking to CDI4 provokes ligand - specific receptor clustering in rafts[ J]. Eur J Immunol,2001,31:3153 -3164.
  • 9Durpuis J, L,arson MG, Ramaehandran SV, et al. Genome scan of sys- temic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1 q [ J ]. Athereselerosis, 2005,182:307 - 314.
  • 10Ross R. Atherosderosls -an inflammatory disease [ J]. N gngl J Med,1999,340(2) :115.

二级参考文献10

  • 1Li Z, Cheng H, Lederer WJ, et al. Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants[J]. Exp Mol Pathol,1997,64:1-11.
  • 2Worth NF, Rolfe BE, Song J, et al. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins[J]. Cell Motil Cytoskeleton,2001,49:130-145.
  • 3Axel DI, Riessen R, Athanasiadis A, et al. Growth factor espression of human arterial smooth cells and endothelial cells in a transfilter coculture system[J]. J Mol Cell Cardiol,1997,29:2967- 2978.
  • 4Reidy MA. In vivo proliferation of vascular smooth muscle cells in vessels with intact endothelial cover(Abstract)[J]. Fed Proc,1986,45:683.
  • 5Gorog P, Kovacs IB. Inhibition of vascular smooth muscle cell migration by intact endothelium is nitric oxide-mediated: interference by oxidised low density lipoproteins[J]. J Vasc Res, 1998,35 :165-169.
  • 6Inoue K, Cynshi O, Kawabe Y, et al. Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits[J]. Atherosclerosis, 2002,161 :353-363.
  • 7Ronnov-Jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts [J]. J Cell Biol,1996,134:67-80.
  • 8Kingsley K, Huff JL, Rust WL, et al. ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5[J]. Biochem Biophys Res Commun,2002,293:1000-1006.
  • 9Berrou E, Bryckaert M. Platelet-derived growth factor inhibits smooth muscle cell adhesion to fibronectin by ERK-dependent and ERK-independent pathways[J]. J Biol Chem,2001,276:39303-39309.
  • 10王睿,高歌.冠状动脉再狭窄的防治研究[J].心脏杂志,2000,12(3):221-223. 被引量:4

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部